SelectQuote (NYSE:SLQT - Get Free Report) released its earnings results on Monday. The company reported ($0.26) earnings per share for the quarter, missing the consensus estimate of ($0.18) by ($0.08), RTT News reports. The company had revenue of $292.26 million for the quarter, compared to the consensus estimate of $275.15 million. SelectQuote had a negative net margin of 2.58% and a negative return on equity of 10.37%. During the same period in the prior year, the firm posted ($0.19) EPS. SelectQuote updated its FY 2025 guidance to EPS.
SelectQuote Stock Up 7.6 %
NYSE:SLQT traded up $0.16 during mid-day trading on Tuesday, hitting $2.19. 1,831,508 shares of the company's stock traded hands, compared to its average volume of 1,024,901. The company has a fifty day moving average of $2.43 and a 200 day moving average of $2.82. SelectQuote has a twelve month low of $1.03 and a twelve month high of $4.46. The company has a market capitalization of $374.64 million, a P/E ratio of -10.40 and a beta of 1.06. The company has a debt-to-equity ratio of 2.01, a quick ratio of 6.84 and a current ratio of 6.84.
Analysts Set New Price Targets
Several brokerages have commented on SLQT. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $4.00 price objective on shares of SelectQuote in a research report on Tuesday, October 29th. Craig Hallum began coverage on SelectQuote in a research report on Monday, September 30th. They issued a "buy" rating and a $4.50 price objective on the stock.
Get Our Latest Stock Analysis on SelectQuote
SelectQuote Company Profile
(
Get Free Report)
SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.
Featured Articles
Before you consider SelectQuote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SelectQuote wasn't on the list.
While SelectQuote currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.